As seen in Supplementary Table S1, even though miRNAs such as miR-223 (Yang et al., 2013), miR-133a, and miR-326 (Ma et al., 2015) particularly target one type of ABC transporters, some other ones comprising miR-122 (Yahya et al., 2018), miR-98, and miR-214 (Hamed et al., 2018) modulate the expression of multi-transporters simultaneously, making them efficient therapeutic agents reversing doxorubicin associated drug resistance in HCC. Here, ABCG2 is linked to hepatocellular carcinoma.